Chronic myelogenous leukemia Chronic myelogenous leukemia (CML) is a cancer of the white blood cells. It causes them to increase in number, crowd out other blood cells, leading to anemia, infection or heavy bleeding. Up until the early 2000’s the main weapon against CML was chemotherapy, but the introduction of drugs called tyrosine kinase inhibitors … Continue reading CIRM funded research could lead to treatment to prevent recurrence of deadly blood cancer
CIRM
Encouraging Progress for Two CIRM Supported Clinical Trials
This past Wednesday was Stem Cell Awareness Day, a day that is meant to remind us all of the importance of stem cell research and the potential it has to treat a wide variety of diseases. On this day, we also released an independent Economic Impact Report that showed how $10.7 Billion (yes, you read … Continue reading Encouraging Progress for Two CIRM Supported Clinical Trials
Rare Disease, Type 1 Diabetes, and Heart Function: Breakthroughs for Three CIRM-Funded Studies
This past week, there has been a lot of mention of CIRM funded studies that really highlight the importance of the work we support and the different disease areas we make an impact on. This includes important research related to rare disease, Type 1 Diabetes (T1D), and heart function. Below is a summary of the … Continue reading Rare Disease, Type 1 Diabetes, and Heart Function: Breakthroughs for Three CIRM-Funded Studies
CIRM-funded Stanford study finds potential diagnostic tool, treatment for Parkinson’s
Dr. Xinnan Wang, a neurosurgeon and author of a study that has identified a molecular pathway apparently responsible for the death of dopaminergic neurons that causes the symptoms of Parkinson's. Of the various neurodegenerative diseases, Parkinson's is the second most common and affects 35 million people world wide. It is caused by the gradual breakdown of … Continue reading CIRM-funded Stanford study finds potential diagnostic tool, treatment for Parkinson’s
Engineered T cells made from stem cells could provide immunity against multiple cancers
Dr. Lily Yang Within all of our bodies there is a special type of "super" immune cell that holds enormous potential. Unlike regular immune cells that can only attack one cancer at a time, these "super" immune cells have the ability to target many types of cancers at once. These specialized cells are known as … Continue reading Engineered T cells made from stem cells could provide immunity against multiple cancers
California Stem Cell and Regenerative Therapy Task Force holds meeting to consider options for patient protection
Dr. Maria Millan, President and CEO of CIRM, attended the meeting to discuss the importance of having systems in place for patient protection. What procedures are in place to ensure the quality and safety of stem cell treatments? How can patients guard against deceptive promotional practices for treatments that have no basis in science? What … Continue reading California Stem Cell and Regenerative Therapy Task Force holds meeting to consider options for patient protection
Scientists at USC untangle the mysteries of cellular reprogramming- a method that could be used to treat diseases
Dr. Justin Ichida, Assistant Professor at USC and lead author of the study Scientists have long tried to repurpose cells in order to potentially treat various types of conditions. This process, called reprogramming, involves changing one type of cell into another, such as a blood cell into a muscle cell or nerve cell. Although the … Continue reading Scientists at USC untangle the mysteries of cellular reprogramming- a method that could be used to treat diseases
CIRM board member Lauren Miller Rogen appointed to California Alzheimer’s Task Force
Lauren Miller Rogen, Hilarity for Charity co-founder and CIRM Board Member California has the largest aging population in the United States. The U.S. Census Bureau has estimated that one in five Californians will be 65 or older by the year 2030. Unfortunately with age comes a wide of health related issues that can arise such … Continue reading CIRM board member Lauren Miller Rogen appointed to California Alzheimer’s Task Force
CIRM-Funded Researchers Develop Chimeric “Mighty Mouse” Model to Study Alzheimer’s Disease
Dr. Mathew Blurton-Jones, leader of team that developed the chimeric "Mighty Mouse" model at the University of California, Irvine In ancient Greek mythology, a Chimera was a creature that was usually depicted as a lion with an additional goat head and a serpent for a tail. Due to the Chimera's animal hybrid nature, the term … Continue reading CIRM-Funded Researchers Develop Chimeric “Mighty Mouse” Model to Study Alzheimer’s Disease
Newly discovered “don’t eat me” signal shows potential for ovarian and triple-negative breast cancer treatment
Stanford researchers have found that cancer cells have a protein called CD24 on their surface that enables them to protect themselves against the body's immune cells. Courtesy of Shutterstock Getting a breast cancer diagnosis is devastating news in and of itself. Currently, there are treatment options that target three different types of receptors, which are … Continue reading Newly discovered “don’t eat me” signal shows potential for ovarian and triple-negative breast cancer treatment
The Stem Cellar 